RE:read the article$21M in cash on Mar 31/21. $17M paid by Kedrion for plasma centres. Still own plasma business and paying for it until Kedrion completes option to buy. Burn of $20.8M in Q1. So, they have under 2 months cash left. Can they sell PRV within 2 months? Or will Thomvest give them more financing with voucher as collateral? Wouldnt that be good? Thomvest/SALP in a high loan position. Equity institutions love that position. Some clown on this board will comment that they have that money. They currently do not. There is nothing to go into Phase 2 and that will obviously take lots of time to see what's next and they are looking to put Phase 1 for their other pipeline stuff "sometime" in 2022 so that gets them very little runway in clinical terms.